Lexby WheresMyMEPGet Pro free

Novo Nordisk A/S has 75 disclosed EU lobbying meetings from 2024-07-16 to 2026-06-02: 17 with the European Commission and 58 with Members of the European Parliament. Source: EU Transparency Register no. 29570313329-11, Commission disclosures and MEP declarations. Methodology

Novo Nordisk A/S

EU lobbying footprint — who they meet, and on what.

Register no.
29570313329-11 ↗
Disclosed meetings
75 (17 Commission · 58 MEP)
Period
2024-07-16 → 2026-06-02

Declared fields of interest: Business and industry · Climate action · Digital economy and society · Energy · Environment · Public health · Research and innovation · Trade

Lobbying profile

as declared 2026-03-13
Category
Companies & groups
Legal status
Corporation
Declared lobbying cost
€2,000,000
Lobbying FTEs
3.55
Members
6
LobbyFacts / Transparency Register source ↗

At a glance

Most-met policy areas
  • Technology4
  • Finance4
  • Trade1
  • Health1
  • Industry1
Commission officials
  • Andreas Schwarz3
  • Dan Jørgensen1
  • Roxana Mînzatu1
  • Ekaterina Zaharieva1
  • Matthias Jorgensen1

Disclosed meetings

Newest first, showing the most recent 60 of 75. EC = European Commission, EP = Member of the European Parliament.

Lobbying in these areas

Who lobbies on Technology & Digital →Who lobbies on Banking & Capital Markets →Who lobbies on Healthcare & Medical Devices →Who lobbies on Manufacturing & Industrial →

Frequently asked

How many EU lobbying meetings has Novo Nordisk A/S disclosed?

Novo Nordisk A/S (EU Transparency Register no. 29570313329-11) appears in 75 disclosed meetings with EU officials and MEPs between 2024-07-16 and 2026-06-02: 17 with the European Commission and 58 with Members of the European Parliament.

What does Novo Nordisk A/S lobby on?

Novo Nordisk A/S's disclosed EU meetings most often concern Technology, Finance, Trade, Health. Every meeting and its topic is listed with its official source on this page.

Who does Novo Nordisk A/S meet in Brussels?

Across its disclosed meetings, Novo Nordisk A/S has met Commission officials including Andreas Schwarz, Dan Jørgensen, Roxana Mînzatu, and MEPs including HANSEN Niels Flemming, SOKOL Tomislav, BOSSE Stine. These are counts of officially disclosed meetings, not a measure of influence.

Primary sources

Every meeting above is a public disclosure by the European Commission or a Member of the European Parliament; counts are of disclosed meetings only and are not a measure of influence. Methodology. Data © European Union (Decision 2011/833/EU) & the European Parliament.

Get the EU lobbying brief

We’ll email you when major new lobbying meetings are disclosed — free, no account, built from public EU data with every entry cited. We only email on real updates.

See how this affects your company →Ask Lex about Novo Nordisk A/S →